SCHEMBL1389965

SCHEMBL1389965

Cn1cc(C(CC(c2ccc(-c3ccc(C(=O)O)c(F)c3)cc2)c2ccc(Cl)cc2Cl)=NO)ccc1=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 3/20 0.37
ADRB1 P08588 3/20 0.36
ADRB3 P13945 3/20 0.36
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
KMT2A Q03164 1/20 0.35
FFAR1 O14842 2/20 0.35
F9 P00740 1/20 0.34
RARB P10826 3/20 0.33
RARA P10276 2/20 0.33
RARG P13631 1/20 0.33
PPARG P37231 1/20 0.33
F11 P03951 1/20 0.32
KLKB1 P03952 1/20 0.32
SRD5A2 P31213 1/20 0.32
MARS1 P56192 1/20 0.32
MDM2 Q00987 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389964 1.00 GPBAR1 (0.37) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1389961 1.00 GPBAR1 (0.37) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1389729 1.00 GPBAR1 (0.37) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1389726 1.00 GPBAR1 (0.37) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1389759 1.00 GPBAR1 (0.37) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1389761 1.00 GPBAR1 (0.37) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1390231 0.94 GPBAR1 (0.38) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1390048 0.94 GPBAR1 (0.38) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1390050 0.94 GPBAR1 (0.38) GPBAR1ADRB1ADRB3MEN1POLB
SCHEMBL1390227 0.94 GPBAR1 (0.38) GPBAR1ADRB1ADRB3MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885ADRB1 3/4885ADRB3 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.